TY - JOUR
T1 - A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum
AU - Ambikairajah, Ananthan
AU - Devenney, Emma
AU - Flanagan, Emma
AU - Yew, Belinda
AU - Mioshi, Eneida
AU - Kiernan, Matthew C.
AU - Hodges, John R.
AU - Hornberger, Michael
N1 - Funding Information:
We are grateful to the patients and their families for their support of our research. This study was supported by Australian Research Council and National Health & Medical Research Council grants. MCK and JRH are supported through a NHMRC Program Grant. MH is supported by an Australian Research Council Research Fellowship.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2014/6
Y1 - 2014/6
N2 - Our objective was to distinguish ALS, ALS-FTD and bvFTD via a novel visual MRI cortical atrophy scale that can be employed in a clinical setting. MRI images of 100 participants (33 ALS, 11 ALS-FTD, 22 bvFTD and 34 controls) were rated in four brain areas: orbitofrontal cortex, anterior temporal pole, anterior cingulate, and motor cortex. Areas were rated on a 5- point Likert scale by two raters blinded to the diagnosis. Results demonstrated that bvFTD patients showed the highest levels of atrophy across all regions, while ALS patients had the lowest atrophy scores. ALS-FTD patients have higher atrophy ratings compared to ALS patients for the motor cortex, anterior cingulate and anterior temporal lobe, with a statistical trend for the orbitofrontal cortex. ALS-FTD patients were not significantly different from bvFTD for any of the brain regions. These findings were confirmed in a post hoc VBM analysis of the same participants. Our study demonstrates that a simple visual MRI rating scale can reliably distinguish ALS, ALS-FTD and bvFTD atrophy patterns in a clinical setting. Motor cortex, anterior cingulate and anterior temporal atrophy emerged as good diagnostic markers for ALS-FTD. Employment of this MRI rating scale can complement clinical diagnostics of patients in the ALS-FTD continuum.
AB - Our objective was to distinguish ALS, ALS-FTD and bvFTD via a novel visual MRI cortical atrophy scale that can be employed in a clinical setting. MRI images of 100 participants (33 ALS, 11 ALS-FTD, 22 bvFTD and 34 controls) were rated in four brain areas: orbitofrontal cortex, anterior temporal pole, anterior cingulate, and motor cortex. Areas were rated on a 5- point Likert scale by two raters blinded to the diagnosis. Results demonstrated that bvFTD patients showed the highest levels of atrophy across all regions, while ALS patients had the lowest atrophy scores. ALS-FTD patients have higher atrophy ratings compared to ALS patients for the motor cortex, anterior cingulate and anterior temporal lobe, with a statistical trend for the orbitofrontal cortex. ALS-FTD patients were not significantly different from bvFTD for any of the brain regions. These findings were confirmed in a post hoc VBM analysis of the same participants. Our study demonstrates that a simple visual MRI rating scale can reliably distinguish ALS, ALS-FTD and bvFTD atrophy patterns in a clinical setting. Motor cortex, anterior cingulate and anterior temporal atrophy emerged as good diagnostic markers for ALS-FTD. Employment of this MRI rating scale can complement clinical diagnostics of patients in the ALS-FTD continuum.
KW - Amyotrophic lateral sclerosis
KW - Frontotemporal dementia
KW - MRI
KW - Visual atrophy rating scale
UR - http://www.scopus.com/inward/record.url?scp=84901484254&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/d22025f5-489c-391b-aaf2-70c9c87a3754/
U2 - 10.3109/21678421.2014.880180
DO - 10.3109/21678421.2014.880180
M3 - Article
C2 - 24533506
AN - SCOPUS:84901484254
SN - 2167-8421
VL - 15
SP - 226
EP - 234
JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
IS - 3-4
ER -